XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF STOCK OPTION (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Equity [Abstract]      
Number of Shares, Outstanding at beginning 23,829 18,596  
Weighted Average Exercise Price, Outstanding at beginning $ 79.00 $ 76.50  
Weighted Average Grant Date Fair Value, Outstanding at beginning $ 103.50 $ 125.00  
Weighted average remaining contractual term, outstanding balance 4 years 1 month 6 days 6 years 1 month 6 days  
Aggregate Intrinsic Value, Outstanding $ 34,333 $ 2,537,245  
Number of Shares, Granted 25,500 2,482  
Weighted Average Exercise Price, Granted $ 3.07 $ 149.00  
Weighted Average Exercise Price, Granted $ 2.58 $ 116.00  
Number of Shares,Options assumed pursuant to acquisition of Magic Med   19,477  
Weighted Average Exercise Price, Options assumed pursuant to acquisition of Magic Med   $ 67.00  
Weighted Average Grant Date Fair Value, Options assumed pursuant to acquisition of Magic Med   $ 92.00  
Number of Shares, Exercised   (2,876)  
Weighted Average Exercise Price, Exercised   $ 11.50  
Weighted Average Grant Date Fair Value, Exercised   $ 284.50  
Number of Shares, Expired, forfeited, or cancelled   (13,850)  
Weighted Average Exercise Price, Expired, forfeited, or cancelled   $ 81.00 $ 84.50
Weighted Average Remaining Contractual Term (years) 5 years 3 months 18 days    
Number of shares, forfeited (1,000)    
Weighted average exercise price, forfeited $ 175.00    
Weighted average grant date fair value, forfeited $ 140.50    
Number of Shares, Outstanding at end 48,329 23,829 18,596
Weighted Average Exercise Price, Outstanding at end $ 37.05 $ 79.00 $ 76.50
Weighted Average Grant Date Fair Value, Outstanding at end 44.82 $ 103.50 $ 125.00
Exercisable shares at end   20,774  
Exercisable weighted average price at end 74.65    
Weighted average grant date fair value, exercisable $ 100.49    
Weighted average remaining contractual term, exercisable 3 years 8 months 12 days